Overview
- 2 inspections across 2 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2023-05-12.
At a glance
Inspections
2
Sites
2
Observations
1
Career since
Jun 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Megafine Pharma (P) Limited | 12 May 2023 | Human Drugs | On file |
| Nephron Sterile Compounding Center, LLC | 7 Jun 2019 | Human Drugs |
Sites inspected
Megafine Pharma (P) LimitedVapi, India1 insp.
Nephron Sterile Compounding Center, LLCWest Columbia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Abdollah Koolivand's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site